Skip to content
Joints & Immunity — Interleukin inhibitorsATC L04AC10

Secukinumab

Prescription only

Biologic for psoriasis and spondyloarthritis.

Starts working
Varies
Half-life
About 27 days
In use since
2015
Pregnancy
Use with caution

Overview

Secukinumab blocks IL-17A and clears skin in many people with moderate to severe psoriasis. It also treats psoriatic arthritis, ankylosing spondylitis and hidradenitis suppurativa. It can worsen inflammatory bowel disease.

How it works

Blocks an inflammation signal central to psoriasis.

Secukinumab belongs to the Interleukin inhibitors. How Interleukin inhibitors work: block one specific immune messenger that drives a particular disease.

Uses

  • Plaque psoriasis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Hidradenitis suppurativa

Available as: pre-filled pen, iv infusion.

Typical dose

Adults
300 mg weekly for 5 weeks, then every 4 weeks.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Cold-like infections
  • Oral thrush
  • Diarrhoea

Serious — get medical help

Uncommon, but need prompt attention

  • New or worse inflammatory bowel disease
  • Serious infections

Warnings

  • TB screening first

Interactions

  • Live vaccines
Check Secukinumab against your own medicines

Pregnancy and breastfeeding

Use with caution

Limited data.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Cosentyx
United Kingdom
Cosentyx
India
Scapho
Australia
Cosentyx

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Why thrush?

IL-17 helps fight yeast infections, so blocking it makes thrush more likely.

Do I need a prescription for Secukinumab?

Yes — Secukinumab is prescription-only in most countries.

Can I take Secukinumab during pregnancy?

Use with caution. Limited data. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.